Measles vaccination of Thai infants by intranasal and subcutaneous routes: Possible interference from respiratory infections

Vaccine

Volumn 15, Issue 3, 1997, Pages 329-334

  Simasathien, S ^a   Migasena, S ^b   Bellini, W ^c   Samakoses, R ^a   Pitisuttitham, P ^b   Bupodom, W ^b   Heath, J ^c   Anderson, L ^c   Bennett, J ^d  

^a PRAMONGKUTKLAO HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d CARTER CENTER   (United States)

Author keywords

intranasal; measles; vaccine

Indexed keywords

MEASLES VACCINE;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNOGENICITY; INFANT; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MEASLES; MEASLES VIRUS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION; THAILAND; VACCINATION;

EID: 0030997950     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00104-7     Document Type: Article

References (34)

1. Expanded Programme on Immunization. Wkly Epidemiol. Rec. 1990, 1, 5-11
2. Aaby, P. and Clements, J. Measles immunization research: a review. Bull. Wld Hlth Organ. 1989, 67, 443-448
3. Garenne, M. and Aaby, P. Pattern of exposure and measles mortality in Senegal. J. Infect. Dis. 1990, 161, 1088-1094
4. Aaby, P. Delayed excess mortality after exposure to measles during the first six months of life. Am. J. Epidemiol. 1990, 132, 211-219
5. Expanded Programme on Immunization Safety of high titre measles vaccines. Wkly Epidemiol. Rec. 1992, 48, 357-364
6. Sabin, A., Arechiga, A. and de Castro, F. et al. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. 1. Different results with undiluted human diploid cell and check embryo fibroblast vaccines. J. Am. Med. Assoc. 1983, 249, 2651-2661
7. Beck, M., Smerdel, S. and Dedic, I. et al. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine. Dev. Biol. Standard. 1986, 65, 95-100
8. Smerdel, S. Clinical trials in Yugoslavia. Workshop on the use of measles vaccine in children under 9 months of age, Centers for Disease Control, Atlanta, Georgia, 21-22 November 1985
9. Dean, A., Dean, J., Coulombier, D. et al. Epi Info, Version 6.02: A word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, GA, USA, 1994
10. Dallal, G. Logistic: A logistic regression program for the IBM PC. Am. Statist. 1988, 42, 272
11. Hummel, K., Erdman, D. and Heath, J. et al. Baculovirus expression of the nucleoprotein gene of measles virus and the utility of the recombinant protein in diagnostic enzyme immunoassays. J. Clin. Microbiol. 1992, 30, 2874-2880
12. Erdman, D., Anderson, L. and Adams, D. et al. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J. Clin. Microbiol. 1991, 29, 1466-1471
13. Anderson, L., Hierholzer, J. and Bingham, P. et al. Micro-neutralization test for respiratory syncytial virus based on an enzyme immunoassay. J. Clin. Microbiol. 1986, 22, 1050-1052
14. Danilov, A. The basis for vaccination against measles by aerosols of live vaccine. In: Respiratory Immunization. USSR Academy of Medical Sciences, Moscow, 1973, pp. 344-345
15. Cahal, N. Some data obtained in Romania by the application of a measles vaccine prepared with the L16 strain in human diploid cells. In: Proceedings of Symposium on Field Trials of Vaccine, 1973, Yugoslavia Academy of Science and Arts, Zagreb
16. Vlatkovic, R., Smerdel, S. and Gvojic, B. et al. Intranasal administration of chick embryo fibroblast Edmonston-Zagreb measles vaccine. Lancet 1985, 1, 520
17. Cernescu, C. and Cahal, N. Antimeasles vaccination by natural routes - experimental background and practical consequences. Rev. Roum. Med. Virol. 1984, 35, 259-271
18. Kress, S., Schluederberg, A. and Hornick, R. et al. Studies with live attenuated measles virus vaccine. Am. J. Dis. Child. 1961, 101, 57-63
19. Black, F. and Sheridan, S. Studies on an attenuated measles virus vaccine. N. Engl. J. Med. 1960, 263, 165-169
20. McCrumb, F., Bulkeley, J. and Hornick, R. et al. Clinical trials with living attenuated measles virus vaccines. Am. J. Publ. Hlth 1962, 52, 11-15
21. Kok, P., Kenya, P. and Ensering, H. Measles immunization with further attenuated heat-stable measles vaccine using 5 different methods of administration. Trans. R. Soc. Trop. Med. Hyg. 1983, 77, 171-176
22. Halsey, N., Boulos, R. and Mode, F. et al. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. N. Engl. J. Med. 1985, 313, 544-549
23. Cutts, F., Nyandu, B. and Markowitz, L. et al. Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5 month-old infants, and of medium or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kingsbasa. Zaire. Vaccine 1994, 12, 1311-1313
24. Cutts, F., Mandala, K. and St. Louis, M. et al. Immunogenicity of high-titer Edmonston-Zagreb measles vaccine in human immunodeficiency virus-infect children in Kinshasa. Zaire. J. Infect. Dis. 1993, 167, 1418-1421
25. Dennehy, P., Saracen, C. and Peter, G. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Pediatrics 1994, 94, 514-516
26. Krober, M., Stracener, C. and Bass, J. et al. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds. J. Am. Med. Assoc. 1991, 265, 2095-2096
27. Pongrithsukda, V., Gluck, R. and Suwatanapongched, S. et al. Trial of Edmonston-Zagreb measles vaccine in infants under nine months. S.E. Asian J. Trop. Med. Publ. Hlth 1991, 22, 347-349
28. Khanum, S., Uddin, N. and Garelick, H. et al. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Lancet 1987, 1, 150-153
29. Markowitz, L., Sepulveda, J. and Diaz-Ortego, J. et al. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N. Engl. J. Med. 1990, 322, 580-587
30. Sabin, A., Arechiga, A., de Castro, F. et al. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response. JAMA 1984, 251, 2363-2371
31. Valdespino, J. Clinical Trials in Mexico, workshop on the use of measles vaccine in children under 9 months-of-age. Centers for Disease Control, Atlanta, Georgia, 21-22 November 1985
32. Johnson, C., Nalin, D. and Chui, L. et al. Measles vaccine immunogenicity in 6-versus 15-month-old infants born to mothers in the measles vaccine era. Pediatrics 1994, 93, 939-944
33. Pannuti, C., de Souza, V. and Sato, H. et al. Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study. Rev. Inst. Med. Trop. Sao Paulo 1990, 32, 450-455
34. McGraw, T.T. Reimmunization following early immunization with measles vaccine: a prospective study. Pediatrics 1986, 771, 45-48